Novartis has lost another NIBR exec to the call of biotech. Blueprint Medicines has added another BMS vet to its roster. And Iovance quietly announced its CEO's departure Wednesday.
Several Philadelphia-area life sciences firms make changes to their C-suites bizjournals.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bizjournals.com Daily Mail and Mail on Sunday newspapers.
Transformative program at Ronald McDonald House better supporting families
Regence BlueCross BlueShield of Utah has teamed up with Ronald McDonald House Charities to provide a first-of-its-kind program to help families with sick children.
Posted at 10:08 AM, Mar 09, 2021
and last updated 2021-03-22 12:18:52-04
A child is sick, and now the family needs to relocate near the hospital where their little one is being treated.
Enter the Ronald McDonald House - an incredible organization surrounding families with the support they need to be near or care for their seriously ill children being treated at area hospitals like Intermountain Primary Children s Hospital, University of Utah, or Shriner s Hospital for Children.
Passage Bio to Host First of a Series of 2021 Virtual R&D Events on January 25
PHILADELPHIA, Jan. 19, 2021 (GLOBE NEWSWIRE) Passage Bio, Inc. (Nasdaq: PASG), a genetic medicines company focused on developing transformative therapies for rare, monogenic central nervous system disorders, today announced it will host a series of virtual Research & Development events in 2021, with the first one scheduled for Monday, January 25, 2021, 11 a.m. to 1 p.m. ET.
The first event will focus on Passage Bio’s lead investigational therapy PBGM01 and its disease target, infantile GM1 gangliosidosis (GM1). Presenters for the event are:
Bruce Goldsmith, Ph.D., chief executive officer, who will present an overview of the Passage Bio pipeline and the GM1 disease and patient experience.